Management of Bacterial and Fungal Infections in the ICU: Diagnosis, Treatment, and Prevention Recommendations

References

• Guest Julian F, Tomas K, Dinah G, Neil W. Modelling the annual NHS costs and outcomes attributable to healthcare-associated infections in England. BMJ open. 2020;10(1):e033367. doi:10.1136/bmjopen-2019-033367
   PubMed Web of Science ®Google Scholar
• Louis VJ, Yasser S, Mervyn S, et al. Prevalence and outcomes of infection among patients in intensive care units in 2017. JAMA. 2020;323(15):1478. doi:10.1001/JAMA.2020.2717
   PubMed Web of Science ®Google Scholar
• Louis VJ, Jordi R, John M, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302(21):2323–2329. doi:10.1001/JAMA.2009.1754
   PubMed Web of Science ®Google Scholar
• Magill Shelley S, Edwards Jonathan R, Wendy B, et al. Multistate point-prevalence survey of health care-associated infections. N Engl J Med. 2014;370(13):1198–1208. doi:10.1056/nejmoa1306801
   PubMed Web of Science ®Google Scholar
• Magnason S, Kristinsson KG, Stefansson T, et al. Risk factors and outcome in ICU-acquired infections. Acta Anaesthesiol Scand. 2008;52(9):1238–1245. doi:10.1111/J.1399-6576.2008.01763.X
   PubMed Web of Science ®Google Scholar
• Pen YS, Yin CY, Shui HH, Der WF. A risk factor analysis of healthcare-associated fungal infections in an intensive care unit: a retrospective cohort study. BMC Infect Dis. 2013;13(1):1–10. doi:10.1186/1471-2334-13-10/TABLES/3
   PubMedGoogle Scholar
• Montagna MT, Caggiano G, Lovero G, et al. Epidemiology of invasive fungal infections in the intensive care unit: results of a multicenter Italian survey (Aurora Project). Infection. 2013;41(3):645. doi:10.1007/S15010-013-0432-0
   PubMed Web of Science ®Google Scholar
• Aleksa D, Branko M, Ivana M, et al. Hospital-acquired infections in the adult intensive care unit—Epidemiology, antimicrobial resistance patterns, and risk factors for acquisition and mortality. Am J Infect Control. 2020;48(10):1211–1215. doi:10.1016/J.AJIC.2020.01.009
   PubMed Web of Science ®Google Scholar
• Chanu R, Kadri Sameer S, Dekker John P, et al. Prevalence of antibiotic-resistant pathogens in culture-proven sepsis and outcomes associated with inadequate and broad-spectrum empiric antibiotic use. JAMA Netw Open. 2020;3(4):e202899–e202899. doi:10.1001/JAMANETWORKOPEN.2020.2899
   PubMed Web of Science ®Google Scholar
• Ecdc. AER for 2017: healthcare-associated infections acquired in intensive care units; 2017.
   Google Scholar
• De Waele Jan J, Murat A, Massimo A, et al. Antimicrobial resistance and antibiotic stewardship programs in the ICU: insistence and persistence in the fight against resistance. A position statement from ESICM/ESCMID/WAAAR round table on multi-drug resistance. Intensive Care Med. 2018;44(2):189–196. doi:10.1007/S00134-017-5036-1/FIGURES/3
   PubMed Web of Science ®Google Scholar
• Matteo B, De Waele Jan J, Philippe E, et al. Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria. Intensive Care Med. 2015;41(5):776–795. doi:10.1007/S00134-015-3719-Z
   PubMed Web of Science ®Google Scholar
• Judith B, Krysan Damian J. Drug resistance and tolerance in fungi. Nat Rev Microbiol. 2020;18(6):319–331. doi:10.1038/s41579-019-0322-2
   PubMed Web of Science ®Google Scholar
• Fisher Matthew C, Ana A-I, Judith B, et al. Tackling the emerging threat of antifungal resistance to human health. Nat Rev Microbiol. 2022;20(9):557–571. doi:10.1038/s41579-022-00720-1
   PubMed Web of Science ®Google Scholar
• Silke S, Ferry H, Rhodes Johanna L, et al. First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist Infect Control. 2016;5(1):35. doi:10.1186/s13756-016-0132-5
   PubMedGoogle Scholar
• Eyre David W, Sheppard Anna E, Hilary M, et al. A candida auris outbreak and its control in an intensive care setting. N Engl J Med. 2018;379(14):1322–1331. doi:10.1056/NEJMoa1714373
   PubMed Web of Science ®Google Scholar
• Chow Nancy A, Lalitha G, Tsay Sharon V, et al. Multiple introductions and subsequent transmission of multidrug-resistant Candida auris in the USA: a molecular epidemiological survey. Lancet Infect Dis. 2018;18(12):1377–1384. doi:10.1016/S1473-3099(18)30597-8
   PubMed Web of Science ®Google Scholar
• Jensen RH, Johansen HK, Søes LM, et al. Posttreatment antifungal resistance among colonizing candida isolates in candidemia patients: results from a systematic multicenter study. Antimicrob Agents Chemother. 2016;60(3):1500–1508. doi:10.1128/AAC.01763-15
   Web of Science ®Google Scholar
• Pristov KE, Ghannoum MA. Resistance of Candida to azoles and echinocandins worldwide. Clin Microbiol Infect. 2019;25(7):792–798. doi:10.1016/j.cmi.2019.03.028
   PubMed Web of Science ®Google Scholar
• Eva A, Ana G, Paula L-E, et al. Fluconazole-resistant Candida parapsilosis clonally related genotypes: first report proving the presence of endemic isolates harbouring the Y132F ERG11 gene substitution in Spain. Clin Microbiol Infect. 2022;28(8):1113–1119. doi:10.1016/j.cmi.2022.02.025
   PubMed Web of Science ®Google Scholar
• Ashutosh S, Singh Pradeep K, Bansidhar T, et al. Emergence of clonal fluconazole-resistant Candida parapsilosis clinical isolates in a multicentre laboratory-based surveillance study in India. J Antimicrob Chemother. 2019;74(5):1260–1268. doi:10.1093/jac/dkz029
   PubMed Web of Science ®Google Scholar
• Magobo Rindidzani E, Lockhart Shawn R, Govender Nelesh P, et al. Fluconazole‐resistant Candida parapsilosis strains with a Y132F substitution in the ERG11 gene causing invasive infections in a neonatal unit, South Africa. Mycoses. 2020;63(5):471–477. doi:10.1111/myc.13070
   PubMed Web of Science ®Google Scholar
• van der Linden Jan WM, Eveline S, Kampinga Greetje A, et al. Clinical implications of azole resistance in aspergillus fumigatus, the Netherlands, 2007–2009. Emerg Infect Dis. 2011;17(10):1846–1854. doi:10.3201/eid1710.110226
   PubMed Web of Science ®Google Scholar
• Martin H, Jon S-G, Walsh Thomas J, et al. Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiolo. Lancet Infect Dis. 2021;21(8):e246–e257. doi:10.1016/S1473-3099(20)30784-2
   PubMed Web of Science ®Google Scholar
• Rawson TM, Wilson RC, Holmes A. Understanding the role of bacterial and fungal infection in COVID-19. Clin Microbiol Infect. 2020. doi:10.1016/j.cmi.2020.09.025
   Web of Science ®Google Scholar
• Damien C, Aurore C, Olivier P, et al. Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICU. Ann Intensive Care. 2020;10(1):1–9. doi:10.1186/S13613-020-00736-X/FIGURES/1
   PubMed Web of Science ®Google Scholar
• Rawson Timothy M, Damien M, Raheelah A, Moore Luke SP, Holmes Alison H. Antimicrobial use, drug-resistant infections and COVID-19. Nat Rev Microbiol. 2020;18:1–2. doi:10.1038/s41579-020-0395-y
   PubMed Web of Science ®Google Scholar
• Rawson TM, Moore LS, Castro-Sanchez E, et al. COVID-19 and the potential long term impact on antimicrobial resistance. J Antimicrob Chemother. 2020;75:1687. doi:10.1093/jac/dkaa194
   Web of Science ®Google Scholar
• Verweij Paul E, Rijnders Bart JA, Brüggemann Roger JM, et al. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion. Intensive Care Med. 2020;46(8):1524–1535. doi:10.1007/s00134-020-06091-6
   PubMed Web of Science ®Google Scholar
• Philipp K, Matteo B, Arunaloke C, et al. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. 2021;21(6):e149–e162. doi:10.1016/S1473-3099(20)30847-1
   PubMed Web of Science ®Google Scholar
• Martin H, Danila S, Rosanne S, et al. COVID-19-associated fungal infections. Nat Microbiol. 2022;7(8):1127–1140. doi:10.1038/s41564-022-01172-2
   PubMed Web of Science ®Google Scholar
• Laura E, Andrew R, Waleed A, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021;49(11):E1063–E1143. doi:10.1097/CCM.0000000000005337
   PubMed Web of Science ®Google Scholar
• Mervyn S, Deutschman Clifford S, Warren SC, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801. doi:10.1001/jama.2016.0287
   PubMed Web of Science ®Google Scholar
• Yu Sean C, Nirmala S, Kevin B, et al. Comparison of early warning scores for sepsis early identification and prediction in the general ward setting. JAMIA Open. 2021;4(3). doi:10.1093/jamiaopen/ooab062
   PubMedGoogle Scholar
• Michael M, Bastian R, Max H, Jutzeler Catherine R, Karsten B. Early prediction of sepsis in the ICU using machine learning: a systematic review. Front Med. 2021;8. doi:10.3389/fmed.2021.607952
   Google Scholar
• Mervyn S, Matt I-K, Manu S-H. Sepsis hysteria: excess hype and unrealistic expectations. Lancet. 2019;394(10208):1513–1514. doi:10.1016/S0140-6736(19)32483-3
   PubMed Web of Science ®Google Scholar
• Gang C, Kailiang X, Fangyuan S, Yuxia S, Ziyuan K, Bangjiang F. Risk factors of multidrug-resistant bacteria in lower respiratory tract infections: a systematic review and meta-analysis. Can J Infect Dis Med Microbiol. 2020;2020. doi:10.1155/2020/7268519
   Web of Science ®Google Scholar
• Miles RT, Esmita C, Moore LSP, et al. Mapping the decision pathways of acute infection management in secondary care among UK medical physicians: a qualitative study. BMC Med. 2016;14(1):208. doi:10.1186/s12916-016-0751-y
   PubMedGoogle Scholar
• Kevin M, Parker Sarah K, Todd James K, Dominguez Samuel R. Implementation of rapid molecular infectious disease diagnostics: the role of diagnostic and antimicrobial stewardship. J Clin Microbiol. 2017;55(3):715–723. doi:10.1128/JCM.02264-16
   PubMed Web of Science ®Google Scholar
• Robert T. Sensitivity, specificity, and predictive values: foundations, pliabilities, and pitfalls in research and practice. Front Public Heal. 2017;5:1–7. doi:10.3389/fpubh.2017.00307
   PubMed Web of Science ®Google Scholar
• Public Health England. UK standards for microbiology investigations. Bacteriology. 2015;55(5.2):1–21.
   Google Scholar
• Khan Zeeshan A, Siddiqui Mohd F, Seungkyung P. Current and emerging methods of antibiotic susceptibility testing. Diagnostics. 2019;9(2):49. doi:10.3390/diagnostics9020049
   Web of Science ®Google Scholar
• Brigitte L, Sylvie D, Arendrup Maiken C, Jacques PJ, Pierre T. How to optimize the use of blood cultures for the diagnosis of bloodstream infections? A State-of-the art. Front Microbiol. 2016;7:697. doi:10.3389/FMICB.2016.00697
   PubMed Web of Science ®Google Scholar
• Anna Å, Emma J, Erika M, et al. EUCAST rapid antimicrobial susceptibility testing (RAST) in blood cultures: validation in 55 European laboratories. J Antimicrob Chemother. 2020;75(11):3230–3238. doi:10.1093/JAC/DKAA333
   PubMed Web of Science ®Google Scholar
• Emma J, Erika M, Gunnar K. The EUCAST rapid disc diffusion method for antimicrobial susceptibility testing directly from positive blood culture bottles. J Antimicrob Chemother. 2020;75(4):968–978. doi:10.1093/JAC/DKZ548
   PubMed Web of Science ®Google Scholar
• van Belkum A, Bachmann TT, Gerd L, et al. Developmental roadmap for antimicrobial susceptibility testing systems. Nat Rev Microbiol. 2018;17(1):51–62. doi:10.1038/s41579-018-0098-9
   Web of Science ®Google Scholar
• van Belkum A, Burnham Carey Ann D, Rossen JWA, Frederic M, Olivier R, Michael DW. Innovative and rapid antimicrobial susceptibility testing systems. Nat Rev Microbiol. 2020;18(5):299–311. doi:10.1038/s41579-020-0327-x
   PubMed Web of Science ®Google Scholar
• Antony C, Guy P, Gilbert G. Applications of MALDI-TOF mass spectrometry in clinical diagnostic microbiology. FEMS Microbiol Rev. 2012;36(2):380–407. doi:10.1111/j.1574-6976.2011.00298.x
   PubMed Web of Science ®Google Scholar
• Osthoff M, Gürtler N, Bassetti S, et al. Impact of MALDI-TOF-MS-based identification directly from positive blood cultures on patient management: a controlled clinical trial. Clin Microbiol Infect. 2017;23(2):78–85. doi:10.1016/j.cmi.2016.08.009
   PubMed Web of Science ®Google Scholar
• Timbrook Tristan T, Morton Jacob B, McConeghy Kevin W, Caffrey Aisling R, Eleftherios M, LaPlante Kerry L. The effect of molecular rapid diagnostic testing on clinical outcomes in bloodstream infections: a systematic review and meta-analysis. Clin Infect Dis. 2017;64(1):15–23. doi:10.1093/cid/ciw649
   PubMed Web of Science ®Google Scholar
• Buchan Blake W, Ledeboer Nathan A. Emerging technologies for the clinical microbiology laboratory. Clin Microbiol Rev. 2014;27(4):783–822. doi:10.1128/CMR.00003-14
   PubMed Web of Science ®Google Scholar
• Wickes Brian L, Wiederhold Nathan P, Harvey TA, Prum RO. Molecular diagnostics in medical mycology. Nat Commun. 2018;9(1):1–13. doi:10.1038/s41467-018-07556-5
   PubMedGoogle Scholar
• Antti V, Hytönen Vesa P, Laitinen Olli H. Modern tools for rapid diagnostics of antimicrobial resistance. Front Cell Infect Microbiol. 2020;10:308. doi:10.3389/FCIMB.2020.00308/BIBTEX
   PubMed Web of Science ®Google Scholar
• Ritu B, Teng Christine B, Cunningham Scott A, et al. Randomized trial of rapid multiplex polymerase chain reaction–based blood culture identification and susceptibility testing. Clin Infect Dis. 2015;61(7):1071–1080. doi:10.1093/cid/civ447
   PubMed Web of Science ®Google Scholar
• Miles RT. Understanding how diagnostics influence antimicrobial decision-making is key to successful clinical trial design. Clin Microbiol Infect. 2023. doi:10.1016/j.cmi.2023.03.010
   Web of Science ®Google Scholar
• Muriel F, Nseir S, Mégarbane B. Respiratory multiplex PCR and procalcitonin to reduce antibiotic exposure in severe SARS-CoV-2 pneumonia: a multicenter randomised controlled trial. Clin Microbiol Infect. 2023. doi:10.1016/j.cmi.2023.01.009
   Web of Science ®Google Scholar
• Anne HC, Bertrand E, Nancy W, et al. Impact of rapid antimicrobial susceptibility testing in gram-negative rod bacteremia: a quasi-experimental study. J Clin Microbiol. 2020;58(9). doi:10.1128/JCM.00360-20
   Web of Science ®Google Scholar
• Vanesa A-V, Cristina S, Timothy P. Impact of rapid susceptibility testing on antimicrobial therapy and clinical outcomes in Gram-negative bloodstream infections. J Antimicrob Chemother. 2022;77(3):771–781. doi:10.1093/jac/dkab449
   PubMed Web of Science ®Google Scholar
• Christensen Alyssa B, Brent F, Tobias P, et al. Impact of a laboratory-developed phenotypic rapid susceptibility test directly from positive blood cultures on time to narrowest effective therapy in patients with gram-negative bacteremia: a prospective randomized trial. Open Forum Infect Dis. 2022;9(7). doi:10.1093/ofid/ofac347
   PubMed Web of Science ®Google Scholar
• Rawson Timothy M, Wilson Richard C, O’Hare D, et al. Optimizing antimicrobial use: challenges, advances and opportunities. Nat Rev Microbiol. 2021;19(12):747–758. doi:10.1038/s41579-021-00578-9
   PubMed Web of Science ®Google Scholar
• Pappas Peter G, Lionakis Michail S, Cavling AM, Luis O-Z, Jan KB. Invasive candidiasis. Nat Rev Dis Prim. 2018;4(1):1–20. doi:10.1038/nrdp.2018.26
   PubMedGoogle Scholar
• Roberts Jason A, Paul Sanjoy K, Murat A, et al. DALI: defining antibiotic levels in intensive care unit patients: are current ??-lactam antibiotic doses sufficient for critically ill patients? Clin Infect Dis. 2014;58(8):1072–1083. doi:10.1093/cid/ciu027
   PubMed Web of Science ®Google Scholar
• Michael O, Martin S, Gianmarco B, Hafiz A-AM, Roberts JA. Prolonged administration of β-lactam antibiotics - a comprehensive review and critical appraisal. Swiss Med Wkly. 2016;146:w14368. doi:10.4414/smw.2016.14368
   PubMed Web of Science ®Google Scholar
• Roberts Jason A, Mohd-Hafiz A-A, Davis Joshua S, et al. Continuous versus intermittent β-lactam infusion in severe sepsis. a meta-analysis of individual patient data from randomized trials. Am J Respir Crit Care Med. 2016;194(6):681–691. doi:10.1164/rccm.201601-0024OC
   PubMed Web of Science ®Google Scholar
• Kollef Marin H, Shorr Andrew F, Matteo B, et al. Timing of antibiotic therapy in the ICU. Crit Care. 2021;25(1). doi:10.1186/S13054-021-03787-Z
   Web of Science ®Google Scholar
• Solen K, Benoit V, Laurence A-L, François TJ. Molecular diagnostic methods for pneumonia: how can they be applied in practice? Curr Opin Infect Dis. 2021;34(2):118–125. doi:10.1097/QCO.0000000000000713
   PubMed Web of Science ®Google Scholar
• Maria PA, Adam S, Anna H, Adam I, Harris Patrick NA. New microbiological techniques for the diagnosis of bacterial infections and sepsis in ICU INCLUDING POINT OF CARE. Curr Infect Dis Rep. 2021;23(8). doi:10.1007/S11908-021-00755-0
   Web of Science ®Google Scholar
• David B, Primrose GB, Francesco B, et al. Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis. Lancet Infect Dis. 2017;17(9):990–1001. doi:10.1016/S1473-3099(17)30325-0
   PubMed Web of Science ®Google Scholar
• Silva Brenda NG, Andriolo Régis B, Atallah Álvaro N, Reinaldo S. De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock. Cochrane Database Syst Rev. 2013;2018(12). doi:10.1002/14651858.CD007934.pub3
   Google Scholar
• Barberena MR, Viteri GJA, Castillo ZWJ, Kessler BF. De-escalation, adequacy of antibiotic therapy and culture positivity in septic patients: an observational study. Rev Bras Ter Intensiva. 2016;28:315–322. doi:10.5935/0103-507X.20160044
   PubMedGoogle Scholar
• Abdul-Aziz Mohd H, Alffenaar Jan Willem C, Matteo B, et al. Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper. Intensive Care Med. 2020;46(6):1127–1153. doi:10.1007/s00134-020-06050-1
   PubMed Web of Science ®Google Scholar
• Stefan H, Friedhelm B, Thorsten B, et al. Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial. Intensive Care Med. 2022;48(3):311–321. doi:10.1007/s00134-021-06609-6
   PubMed Web of Science ®Google Scholar
• Leonel L, Belen E, Sergio R-E. Current understanding in source control management in septic shock patients: a review. Ann Transl Med. 2016;4(17):330. doi:10.21037/atm.2016.09.02
   PubMed Web of Science ®Google Scholar
• De Waele Jan J, Massimo G, Ignacio M-L. Source control in the management of sepsis and septic shock. Intensive Care Med. 2022;48(12):1799–1802. doi:10.1007/s00134-022-06852-5
   PubMed Web of Science ®Google Scholar
• Marshall John C, Al Naqbi A. Principles of source control in the management of sepsis. Crit Care Clin. 2009;25(4):753–768. doi:10.1016/j.ccc.2009.08.001
   PubMed Web of Science ®Google Scholar
• O’Grady Naomi P, Mary A, Burns Lillian A, et al. Guidelines for the Prevention of Intravascular Catheter-related Infections. Clin Infect Dis. 2011;52(9):e162–e193. doi:10.1093/cid/cir257
   PubMed Web of Science ®Google Scholar
• Peter P, Dale N, Sean B, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006;355(26):2725–2732. doi:10.1056/NEJMoa061115
   PubMed Web of Science ®Google Scholar
• Girard Timothy D, Kress John P, Fuchs Barry D, et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet. 2008;371(9607):126–134. doi:10.1016/S0140-6736(08)60105-1
   PubMed Web of Science ®Google Scholar
• Augustes R, Ho KM. meta-analysis of randomised controlled trials on daily sedation interruption for critically ill adult patients. Anaesth Intensive Care. 2011;39(3):401–409. doi:10.1177/0310057X1103900310
   PubMed Web of Science ®Google Scholar
• Sangeeta M. Daily sedation interruption in mechanically ventilated critically ill patients cared for with a sedation protocol. JAMA. 2012;308(19):1985. doi:10.1001/jama.2012.13872
   PubMed Web of Science ®Google Scholar
• Julie S, Anthony T, Walter Z, et al. Core components for effective infection prevention and control programmes: new WHO evidence-based recommendations. Antimicrob Resist Infect Control. 2017;6(1):6. doi:10.1186/s13756-016-0149-9
   PubMedGoogle Scholar
• Didier P, Stéphane H, Stephan H, et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Lancet. 2000;356(9238):1307–1312. doi:10.1016/S0140-6736(00)02814-2
   PubMed Web of Science ®Google Scholar
• Sarah T-S, Hans P, Widmer Andreas F. Hand hygiene in the intensive care unit. Crit Care Med. 2010;38:S299–S305. doi:10.1097/CCM.0b013e3181e6a23f
   PubMed Web of Science ®Google Scholar
• Kim Janice J, Turner Nancy E, Emily H, et al. Corynebacterium striatum outbreak among ventilated COVID-19 patients in an acute care hospital – California, 2021. Open Forum Infect Dis. 2021;8(Supplement_1):S495–S496. doi:10.1093/ofid/ofab466.998
   Google Scholar
• Charles HW, Huckabee Charmaine M, O’Grady Naomi P, et al. Intervention to reduce transmission of resistant bacteria in intensive care. N Engl J Med. 2011;364(15):1407–1418. doi:10.1056/NEJMoa1000373
   PubMed Web of Science ®Google Scholar
• De Angelis G, Cataldo MA, De Waure C, et al. Infection control and prevention measures to reduce the spread of vancomycin-resistant enterococci in hospitalized patients: a systematic review and meta-analysis. J Antimicrob Chemother. 2014;69(5):1185–1192. doi:10.1093/jac/dkt525
   PubMed Web of Science ®Google Scholar
• Gerding Dale N, Muto Carlene A, Owens J, Robert C. Measures to Control and Prevent Clostridium difficile Infection. Clin Infect Dis. 2008;46(s1):S43–S49. doi:10.1086/521861
   PubMedGoogle Scholar
• Nizam D. Surveillance and outbreak management. Man Infect Prev Control. 2019;2019:68–94.
   Google Scholar
• Hammond Naomi E, John M, Ian S, et al. Association between selective decontamination of the digestive tract and in-hospital mortality in intensive care unit patients receiving mechanical ventilation. JAMA. 2022;328(19):1922. doi:10.1001/jama.2022.19709
   PubMed Web of Science ®Google Scholar
• Miles RT, Prockter MLS, Christopher HJ, Hugo D, Helen HA. Plasmid-mediated colistin resistance mechanisms: is it time to revise our approach to selective digestive decontamination? Lancet Infect Dis. 2016;16(2):149–150. doi:10.1016/S1473-3099(15)00539-3
   PubMed Web of Science ®Google Scholar
• Catherine B, Emma B, Timothy C, et al. Effect of selective decontamination of the digestive tract on hospital mortality in critically ill patients receiving mechanical ventilation. JAMA. 2022;328(19):1911. doi:10.1001/jama.2022.17927
   PubMed Web of Science ®Google Scholar
• Niccolò B, Jonas M, Marci D, et al. Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 Update. Infect Control Hosp Epidemiol. 2022;43(5):553–569. doi:10.1017/ice.2022.87
   PubMed Web of Science ®Google Scholar
• Julian B, Annette R, Peter H, et al. ‘Matching Michigan’: a 2-year stepped interventional programme to minimise central venous catheter-blood stream infections in intensive care units in England. BMJ Qual Saf. 2013;22(2):110–123. doi:10.1136/bmjqs-2012-001325
   PubMed Web of Science ®Google Scholar
• Jordi R, Hartmut L, Giuseppe C, Robert M. A European care bundle for prevention of ventilator-associated pneumonia. Intensive Care Med. 2010;36(5):773–780. doi:10.1007/s00134-010-1841-5
   PubMed Web of Science ®Google Scholar
• Hellyer Thomas P, Victoria E, Peter W, John SA. The Intensive Care Society recommended bundle of interventions for the prevention of ventilator-associated pneumonia. J Intensive Care Soc. 2016;17(3):238–243. doi:10.1177/1751143716644461
   PubMedGoogle Scholar
• Levy Mitchell M, Phillip DR, Townsend Sean R, et al. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med. 2010;36(2):222–231. doi:10.1007/s00134-009-1738-3
   PubMed Web of Science ®Google Scholar
• Julien P, Lauro D, Anne B, et al. Risk factors for candidemia: a prospective matched case-control study. Critical Care. 2020;24:1. doi:10.1186/s13054-020-2766-1
   PubMed Web of Science ®Google Scholar
• Jenks Jeffrey D, Nam Hannah H, Martin H. Invasive aspergillosis in critically ill patients: review of definitions and diagnostic approaches. Mycoses. 2021;64(9):1002–1014. doi:10.1111/MYC.13274
   PubMed Web of Science ®Google Scholar
• Ibrahim Ashraf S, Brad S, Walsh Thomas J, Kontoyiannis Dimitrios P. Pathogenesis of mucormycosis. Clin Infect Dis. 2012;54(SUPPL. 1):1–7. doi:10.1093/cid/cir865
   PubMedGoogle Scholar
• Lewis WP, Price Jessica S, Matthijs B. Pneumocystis jirovecii pneumonia: epidemiology, clinical manifestation and diagnosis. Curr Fungal Infect Rep. 2019;13(4):260–273. doi:10.1007/s12281-019-00349-3
   Web of Science ®Google Scholar
• Diling W, Chenfang W, Siye Z, Yanjun Z. Risk factors of ventilator-associated pneumonia in critically III patients. Front Pharmacol. 2019;10. doi:10.3389/FPHAR.2019.00482
   Web of Science ®Google Scholar
• Bonten Marc JM, Kollef Marin H, Hall Jesse B. Risk factors for ventilator-associated pneumonia: from epidemiology to patient management. Clin Infect Dis. 2004;38(8):1141–1149. doi:10.1086/383039/2/38-8-1141-TBL003.GIF
   PubMed Web of Science ®Google Scholar
• François TJ, Etienne R, François B, Alexis T, Matteo B. Bloodstream infections in critically ill patients: an expert statement. Intensive Care Med. 2020;46(2):266. doi:10.1007/S00134-020-05950-6
   PubMed Web of Science ®Google Scholar
• Kiang LE, Alvin T, Gillian L, et al. Risk factors associated with urinary tract infections in intensive care patients. Infect Dis Heal. 2016;21(2):62–66. doi:10.1016/J.IDH.2016.03.004
   Google Scholar
• Rampini Silvana K, Bloemberg Guido V, Keller Peter M, et al. Broad-range 16S rRNA gene polymerase chain reaction for diagnosis of culture-negative bacterial infections. Clin Infect Dis. 2011;53(12):1245–1251. doi:10.1093/cid/cir692
   PubMed Web of Science ®Google Scholar
• Pepper Dominique J, Junfeng S, Chanu R, et al. Procalcitonin-guided antibiotic discontinuation and mortality in critically ill adults: a systematic review and meta-analysis. Chest. 2019;155(6):1109. doi:10.1016/J.CHEST.2018.12.029
   PubMed Web of Science ®Google Scholar
• Liliana S, France G, Amre Devendra K, Patrick S-L, Jacques L. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004;39(2):206–217. doi:10.1086/421997
   PubMed Web of Science ®Google Scholar
• Von Dach E, Albrich Werner C, Sophie BA, et al. Effect of C-reactive protein–guided antibiotic treatment duration, 7-day treatment, or 14-day treatment on 30-day clinical failure rate in patients with uncomplicated gram-negative bacteremia: a randomized clinical trial. JAMA. 2020;323(21):2160–2169. doi:10.1001/JAMA.2020.6348
   PubMed Web of Science ®Google Scholar
• Rawson Timothy M, Esmita C, Moore Luke SP, et al. Exploring the Use of C-Reactive Protein to Estimate the Pharmacodynamics of Vancomycin. Ther Drug Monitor. 2018;40(3):315–321. doi:10.1097/FTD.0000000000000507
   PubMed Web of Science ®Google Scholar
• Ramos-Martín V, Neely MN, McGowan P, et al. Population pharmacokinetics and pharmacodynamics of teicoplanin in neonates: making better use of C-reactive protein to deliver individualized therapy. J Antimicrob Chemother. 2016;71:dkw295. doi:10.1093/jac/dkw295
   Web of Science ®Google Scholar
• Clancy Cornelius J, Hong NM. Diagnosing invasive candidiasis. J Clin Microbiol. 2018;56(5). doi:10.1128/JCM.01909-17
   Web of Science ®Google Scholar
• Małgorzata M, Thierry C, Maurizio S, Daniel P, Claudio V. The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia. Crit Care. 2010;14(6). doi:10.1186/CC9365
   Web of Science ®Google Scholar
• Tomer A, Itzhak L, Hannah S, Dafna Y, Leonard L, Mical P. Diagnostic accuracy of PCR alone compared to galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis: a systematic review. J Clin Microbiol. 2012;50(11):3652–3658. doi:10.1128/JCM.00942-12/SUPPL_FILE/ZJM999092057SO2.PDF
   PubMed Web of Science ®Google Scholar
• Huurneman Luc J, Michael N, Anette V, et al. Pharmacodynamics of voriconazole in children: further steps along the path to true individualized therapy. Antimicrob Agents Chemother. 2016;60(4):2336–2342. doi:10.1128/AAC.03023-15
   PubMed Web of Science ®Google Scholar
• Karageorgopoulos Drosos E, Vouloumanou Evridiki K, Fotinie N, Argyris M, Rafailidis Petros I, Falagas Matthew E. β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. Clin Infect Dis. 2011;52(6):750–770. doi:10.1093/CID/CIQ206
   PubMed Web of Science ®Google Scholar
• Kidd Sarah E, Chen Sharon CA, Wieland M, Halliday Catriona L, New A. Age in molecular diagnostics for invasive fungal disease: are we ready? Front Microbiol. 2020;10:2903. doi:10.3389/FMICB.2019.02903/BIBTEX
   PubMed Web of Science ®Google Scholar
• Antoni T, Niederman Michael S, Jean C, et al. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia. Eur Respir J. 2017;50(3):1700582. doi:10.1183/13993003.00582-2017
   PubMed Web of Science ®Google Scholar
• Kalil Andre C, Metersky Mark L, Michael K, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American Thoracic Society. Clin Infect Dis. 2016;63(5):e61–e111. doi:10.1093/cid/ciw353
   PubMedGoogle Scholar
• Shi Y, Huang Y, Tian-Tuo Z, et al. Chinese guidelines for the diagnosis and treatment of hospital-acquired pneumonia and ventilator-associated pneumonia in adults (2018 Edition). J Thorac Dis. 2019;11(6):2581–2616. doi:10.21037/jtd.2019.06.09
   PubMed Web of Science ®Google Scholar
• Boyles Tom H, Adrian B, Calligaro Greg L, et al. Erratum to South African guideline for the management of community-acquired pneumonia in adults. J Thorac Dis. 2018;10(8):E673–E675. doi:10.21037/jtd.2018.07.137
   PubMed Web of Science ®Google Scholar
• Massimo S, Federico C, Yoram K, et al. WSES/GAIS/SIS-E/WSIS/AAST global clinical pathways for patients with intra-abdominal infections. World J Emerg Surg. 2021;16(1):49. doi:10.1186/s13017-021-00387-8
   PubMed Web of Science ®Google Scholar
• Solomkin Joseph S, Mazuski John E, Bradley John S, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the surgical infection society and the infectious diseases society of America. Clin Infect Dis. 2010;50(2):133–164. doi:10.1086/649554
   PubMed Web of Science ®Google Scholar
• Mazuski John E, Tessier Jeffrey M, May Addison K, et al. The surgical infection society revised guidelines on the management of intra-abdominal infection. Surg Infect. 2017;18(1):1–76. doi:10.1089/sur.2016.261
   PubMed Web of Science ®Google Scholar
• Mermel Leonard A, Michael A, Emilio B, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the infectious diseases Society of America. Clin Infect Dis. 2009;49(1):1–45. doi:10.1086/599376
   PubMed Web of Science ®Google Scholar
• Soichi A, Masashi K, Shin K, Hiroshi S, Toshihiko M. The JAID/JSC guidelines for management of infectious diseases 2017 – sepsis and catheter-related bloodstream infection. J Infect Chemother. 2021;27(5):657–677. doi:10.1016/j.jiac.2019.11.011
   PubMed Web of Science ®Google Scholar
• CDC. Guidelines for prevention of catheter-associated urinary tract infections; 2020.
   Google Scholar
• NICE guidelines. Urinary tract infection: antimicrobial prescribing; 2018.
   Google Scholar
• Massimo S, Xavier G, Hardcastle Timothy C, et al. WSES/SIS-E consensus conference: recommendations for the management of skin and soft-tissue infections. World J Emerg Surg. 2018;13(1):58. doi:10.1186/s13017-018-0219-9
   PubMedGoogle Scholar
• Stevens Dennis L, Bisno Alan L, Chambers Henry F, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases Society of America. Clin Infect Dis. 2014;59(2):e10–e52. doi:10.1093/cid/ciu296
   PubMed Web of Science ®Google Scholar
• Alexandra P, Schmid Marie N, Pierre P, et al. Impact of environmental hygiene interventions on healthcare-associated infections and patient colonization: a systematic review. Antimicrob Resist Infect Control. 2022;11(1):38. doi:10.1186/s13756-022-01075-1
   PubMed Web of Science ®Google Scholar
• NHS England and NHS Improvement. Health Technical Memorandum 03–01 Specialised ventilation for healthcare premises Part A: the concept, design, specification, installation and acceptance testing of healthcare ventilation systems; 2021.
   Google Scholar
• Tacconelli E. Screening and isolation for infection control. J Hosp Infect. 2009;73(4):371–377. doi:10.1016/j.jhin.2009.05.002
   PubMed Web of Science ®Google Scholar
• Lavallée Jacqueline F, Gray Trish A, Dumville J, Wanda R, Nicky C. The effects of care bundles on patient outcomes: a systematic review and meta-analysis. Implement Sci. 2017;12(1):142. doi:10.1186/s13012-017-0670-0
   PubMedGoogle Scholar
• National Institute for Health & Care Excellence (NICE). Surgical site infections: prevention and treatment. NICE. 2022;2019:15.
   Google Scholar
• Niels W, Boldingh Quirine JJ, Boermeester Marja A, de Jonge Stijn W. Perioperative care bundles for the prevention of surgical-site infections: meta-analysis. Br J Surg. 2022;109(10):933–942. doi:10.1093/bjs/znac196
   PubMed Web of Science ®Google Scholar
• Evelyn L, Nicolle Lindsay E, Coffin Susan E, et al. Strategies to prevent catheter-associated urinary tract infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol. 2014;35(5):464–479. doi:10.1086/675718
   PubMed Web of Science ®Google Scholar
• Jennifer M, Rogers Mary AM, Krein Sarah L, Fakih Mohamad G, Olmsted Russell N, Sanjay S. Reducing unnecessary urinary catheter use and other strategies to prevent catheter-associated urinary tract infection: an integrative review. BMJ Qual Saf. 2014;23(4):277–289. doi:10.1136/bmjqs-2012-001774
   PubMed Web of Science ®Google Scholar